Please assess the completion status of the following clinical trial:

Trial Title: Natriuretic Effect of GLP-1in Healthy Non Obese Subjects

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: SINGLE
- Phase: EARLY_PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~Inclusion criteria:~* Participant is ≥18 and ≤70 years of age on day of signing informed consent~* Participant is a male, or a female who is unlikely to conceive, as indicated by at least one yes answer to the following questions:~  * Patient is a surgically sterilized female~ * Patient is a postmenopausal female ≥45 years of age with \>2 years since last menses~ * Patient is a non-sterilized, premenopausal female and agrees to abstain from heterosexual activity or to use an adequate method of contraception ( Note: Acceptable methods of birth control are: hormonal contraceptive, intrauterine device (IUD), diaphragm with spermicide, contraceptive sponge, condom, or vasectomy)~* BMI ≥185 and ≤25~* Healthy as determined by:~  * Complete medical history, physical exam and~ * Standard 12-lead EKG~ * Complete blood count, blood chemistry , urinalysis with microscopy~ * Kidney USG~* Participant understands the study procedures, and risks involved with the study and voluntarily agree to participate by giving informed written consent.~Exclusion Criteria:• History of hypertension, diabetes (ADA guidelines), kidney disease~o Participant has impaired renal function defined as glomerular filtration lower than 90 calculated by Cockcroft-Gault formula and 24 creatinine, also by urinary protein excretion \> 200 mg/day or continuing active urinary sediment~* History of myocardial infarction, cerebrovascular accident or transient ischemic attack~* History of malignancy within last 5 years~* Current febrile state~* Participant is pregnant or nursing woman~* Failure to give informed consent or comply with the protocol~* Participant has received treatment with an investigational drug within the prior 3 months or is otherwise participating in another clinical trial

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: t

Study Arms:
- Saline infusion (Type: ACTIVE_COMPARATOR): infusion of saline
- Saline infusion with GLP1 (Type: ACTIVE_COMPARATOR): infusion of saline with GLP1

Based on this trial design, predict the completion outcome and termination type (if applicable).